NCT04617990

Brief Summary

The aim of this study is to identify the knowledge , attitude and practice toward PPI use among doctors in Egypt

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
5,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Dec 2020

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 31, 2020

Completed
5 days until next milestone

First Posted

Study publicly available on registry

November 5, 2020

Completed
26 days until next milestone

Study Start

First participant enrolled

December 1, 2020

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2021

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2021

Completed
Last Updated

November 5, 2020

Status Verified

October 1, 2020

Enrollment Period

1 year

First QC Date

October 31, 2020

Last Update Submit

October 31, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • five points likert-scale score being

    5 for 'completely agree', 4 for 'almost agree', 3 for 'indifferent', 2 for 'almost disagree', and 1 for 'completely disagree'.

    one year

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

1. Doctors who have completed graduation-MBBCH and have undergone one year internship training but have not yet obtained postgraduate degree. 2. PhD , M.D. or M.S. or those who have obtained a specialist postgraduate degree.

You may qualify if:

  • Physicians dealing with PPI therapy in their specialty including general practitioners, gastroenterologists and non gastroenterologist (hepatologists, otolaryngolists, surgeons, anesthesiologists, pediatriticians and internal medicine physicians.)
  • Who gave consent to participate at the beginning of the questionnaire.

You may not qualify if:

  • who refuse to gave consent to participate

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Behavior

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Ahmed Nassar Ibrahim

Study Record Dates

First Submitted

October 31, 2020

First Posted

November 5, 2020

Study Start

December 1, 2020

Primary Completion

December 1, 2021

Study Completion

December 31, 2021

Last Updated

November 5, 2020

Record last verified: 2020-10